| No. |
PRODUCT |
THERAPEUTIC CLASS |
COMPANY |
| 1. |
Rilutek Tablet [Riluzole 50mg] |
Others (Neuroprotective) |
Rhone-Poulene (M) Sdn. Bhd. |
| 2. |
Zyprexa 5mg Tablet [Olanzapine] |
For the acute and maintenance treatment of schizophrenia and
other psychoses where positive symptom (e.g., delusions,
hallcinations, disordered thinking, hostility and suspiciousness)
and/or negative symptoms (e.g., flattened affect, emotional and
social withdrawal, poverty of speech) are prominent. Olanzapine is
effective in maintaining the clinical improvement during continuing
therapy in patients who have shown initial treatment
response. |
Eli Lilly (M) Sdn. Bhd. |
| 3. |
Zyprexa 7.5mg Tablet [Olanzapine] |
For the acute and maintenance treatment of schizophrenia and
other psychoses where positive symptom (e.g., delusions,
hallcinations, disordered thinking, hostility and suspiciousness)
and/or negative symptoms (e.g., flattened affect, emotional and
social withdrawal, poverty of speech) are prominent. Olanzapine is
effective in maintaining the clinical improvement during continuing
therapy in patients who have shown initial treatment
response. |
Eli Lilly (M) Sdn. Bhd. |
| 4. |
Zyprexa 10mg Tablet [Olanzapine] |
For the acute and maintenance treatment of schizophrenia and
other psychoses where positive symptom (e.g., delusions,
hallcinations, disordered thinking, hostility and suspiciousness)
and/or negative symptoms (e.g., flattened affect, emotional and
social withdrawal, poverty of speech) are prominent. Olanzapine is
effective in maintaining the clinical improvement during continuing
therapy in patients who have shown initial treatment
response. |
Eli Lilly (M) Sdn. Bhd. |
| 5. |
Rantudil Capsule 60mg [Acemetacin] |
Pain and restricted mobility associated with:
chronic rheumarthritis (chronic
polyarthritis, rheumatoid arthritis)
chronic rheumarthritis
with psoriatic arthritis
state of acute irritation due to
degenerative joint disease, particularly of the large joints and
spinal coloum (activated arthrosis/spondylarthrosis)
Bekhterevs disease (rheumatoid spondylitis)
Gout
attacks
Inflammation of joints, muscles or tendons,
tenosynovitis, bursitis
Lumbago-sciatica
State of
imflammation and swelling after operations and blunt
injuries
Inflammation of superficial veins
(thrombophlebitis) and other vessels (vasculitis) |
Bayer (M) Sdn. Bhd. |
| 6. |
Omniscan 0.5mmol/ml, 5ml [Gadodiamide] |
Contrast medium for cranial and spinal magnetic resonance
imaging (MRI) for intravenous administration. The product provides
contrast enhancement structures or lesions in the CN |
Kyowa Hakko (M) Sdn. Bhd. |
| 7. |
Omniscan
0.5mmol/ml, 10ml [Gadodiamide] |
Contrast medium for cranial and spinal magnetic resonance
imaging (MRI) for intravenous administration. The product provides
contrast enhancement structures or lesions in the CNS. |
Kyowa
Hakko (M) Sdn. Bhd. |
| 8. |
Omniscan 0.5mmol/ml, 15ml [Gadodiamide] |
Contrast medium for cranial and spinal magnetic resonance
imaging (MRI) for intravenous administration. The product provides
contrast enhancement structures or lesions in the CNS. |
Kyowa Hakko (M) Sdn. Bhd. |
| 9. |
Omniscan 0.5mmol/ml, 20ml [Gadodiamide] |
Contrast
medium for cranial and spinal magnetic resonance imaging (MRI) for
intravenous administration. The product provides contrast
enhancement structures or lesions in the CNS. |
Kyowa
Hakko (M) Sdn. Bhd. |
